BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18852086)

  • 1. Hepatocellular carcinoma: development and early detection.
    Robinson P
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S128-31. PubMed ID: 18852086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT and MRI of hepatocellular carcinoma: an update.
    Ayyappan AP; Jhaveri KS
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to detect hepatocellular carcinoma in cirrhosis.
    Ward J; Robinson PJ
    Eur Radiol; 2002 Sep; 12(9):2258-72. PubMed ID: 12195479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
    J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course of small nodular lesions with intranodular preserved portal supply in cirrhotic liver.
    Fukunaga T; Kudo M; Tochio H; Okabe Y; Orino A
    Oncology; 2007; 72 Suppl 1():24-9. PubMed ID: 18087179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of HCC.
    Ayuso C; Rimola J; GarcĂ­a-Criado A
    Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guest editor's introduction: hepatocellular nodules in liver cirrhosis: imaging update 2011.
    Choi BI
    Abdom Imaging; 2011 Jun; 36(3):230-1. PubMed ID: 21267564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance.
    Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V
    AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules.
    Jeong YY; Yim NY; Kang HK
    AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.
    Giorgio A; Montesarchio L; Gatti P; Amendola F; Matteucci P; Santoro B; Merola MG; Merola F; Coppola C; Giorgio V
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):205-11. PubMed ID: 27308652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
    Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.